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Abstract
An often associated drawback with Baeyer-Villiger monooxygenases, that hinders its application in
industrial synthesis, is its poor operational stability. Furthermore, these biocatalysts frequently suffer
from substrate/product inhibition and require from the costly NADPH cofactor. 
In this work, a thermostable Cyclohexanone monooxygenase (TmCHMO) was immobilized and used in
the synthesis  of  trimethyl-ε-caprolactone (CHL).  As  a  cofactor  regeneration enzyme,  a  novel  and
highly active Glucose dehydrogenase (GDH-01) was successfully immobilized for the first time on four
different methacrylate supports and on amino-functionalized agarose. This last matrix was chosen to
study the recyclability potential of GDH-01 in the target reaction as it presented an immobilization
yield of 76.3 ± 0.7% and a retained activity of 62.6 ± 2.3%, the highest metrics among the supports
tested.  
Both immobilized enzymes were studied either separately or together in six reaction cycles (30 mL;
[substrate] = 132.5 mM). When both enzymes were used in its immobilized formulation, 2.8 g of CHL
could be synthesized. The reaction yield reached almost completion in the first two cycles and slightly
dropped from the third cycle reaching 57.2% in the sixth. A biocatalyst yield of 37.3 g CHL g -1 of
TmCHMO and 474.2 g CHL g-1 of GDH-01 were obtained. These values represent a 3.6-fold and 1.9-
fold increase respectively, compared with a model reaction where both enzymes were used in its
soluble form. 
Keywords: trimethyl-ε-caprolactone; Baeyer-Villiger monooxygenase; cofactor regeneration; re-
cycling; immobilized enzymes biocatalyst yield.
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1. Introduction
Process chemists have long considered biocatalysis as a good alternative to the conventional routes in
chemical manufacturing  [1]. The use of whole cells, isolated enzymes or immobilized enzymes has
often proven to be a greener, sustainable and more profitable way to catalyze such chemical reactions
[2]. The industry has already adopted bioconversions, for example, for the production of amino acids
[3], lactic acid, succinic acid or 3-hydroxypropionic acid [4] among many others [5,6].
In the case of the concerned reaction, Baeyer-Villiger oxidations are well known since their discovery
in 1899  [7]. The chemical route though, usually implies a limited regio-selectivity (to the sterically
more hindered side), the use of hazardous and pollutant solvents and halogenated oxidants [8–10].
At the same time, the transformation of ketones into esters or cyclic ketones into lactones can also be
accomplished by the so called Baeyer-Villiger monooxygenases (BVMOs) [11–13]. The first evidence
was provided by Fired et al. in 1953 with the conversion of progesterone to testololactone [14]. The
enzymatic  alternative  is  often  associated  with  milder  aqueous  conditions,  the  use  of  oxygen  as
oxidant and higher selectivity  [15]. However, their implementation is hindered by some drawbacks
that  may come with  biocatalysts  and specially  with  monooxygenases  [16,17].  BVMOs have been
suffering from low operational stability, substrate and product inhibition and the use of the costly
NADPH cofactor [11,12,18]. 
These  limitations  can  be  tackled  mainly  by  three  strategies:  protein  engineering  [19],  reaction
engineering  [20] and immobilization [21,22]. There are many are the examples of BVMOs that had
been engineered either by means of directed evolution or rational design  [15,23]. For example, a
recent work by Kathleen  et al. demonstrated that certain conserved residues in the active site of
BVMOs, when altered, lead to modified regioselectivity [24,25]. At the same time, the substrate and
product inhibition can be overcome using a different approach  [26,27]. The substrate feeding and
product removal strategy (SFPR) has been applied for BVMOs processes using resins like Optipore L-
493 or Lewatit VPOC 1163 [28,29]. Finally, immobilization of enzymes is a well-known procedure that
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often  confers  improved  operational  and  storage  stability,  allows  the  possibility  to  operate  in
continuous mode, facilitates the isolation and purification of the product and allows the re-utilization
of the biocatalyst [30–32]. 
In this sense, one of the first contributions was from Walsh et al. who immobilized a cyclohexanone
monooxygenase (CHMO) together with a glucose dehydrogenase (GDH), as a cofactor regeneration
enzyme, onto polyacrylamide gel and used it in 1 liter reactions for 10 days  [33]. Interestingly, the
covalent immobilization of BVMOs together with a GDH is one of the most widely used combinations
in the literature [11]. In this work, this same strategy was applied for the production of the two regio-
isomers  of  trimethyl-ε-caprolactone  (CHL)  from  3,3,5-trimethylcyclohexanone  (TMCH).  Two  novel
enzymes were used for this purpose, the thermostable CHMO from Thermocrispum municipale DSM
44069 (TmCHMO; EC 1.14.13.22) [34] and the highly active GDH-01 (EC 1.1.1.47) (Figure 1). 
Figure  1.  Biocatalyzed  oxidation  of  the  branched  substrate  3,3,5-trimethylcyclohexanone  (1)  (TMCH)  to  a
mixture  of  β,β,δ-trimethyl-ε-caprolactone  (1a)  and  β,δ,δ-trimethyl-ε-caprolactone  (1b)  (CHL)  with  a  two-
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enzyme  system  using  Glucose  dehydrogenase  (GDH)  to  regenerate  the  NADPH  using  D-(+)-Glucose  as  a
sacrificial substrate.
Immobilization of TmCHMO has been previously conducted by Delgove  et al. and the derivate was
also used for the synthesis of CHL [35]. In order to regenerate the cofactor, an immobilized GDH from
Thermoplasma acidophilum was used in that case. 
In the present work, in contrast, the immobilization of the novel GDH-01 has been studied for the first
time on a broad variety of supports presenting different functional groups and characteristics  [36].
The immobilized derivate served as biocatalyst together with the immobilized TmCHMO in the target
reaction and they were re-used for six cycles. The substrate was continuously dosed, in order to avoid
substrate inhibition, until 132.5 mM were reached. This substrate concentration represents a more
than 13-fold increase compared with the previous work aforementioned.
2. Materials and methods
2.1. Chemicals and supports
D-(+)-glucose (> 97.5%) and ethyl acetate (> 99.9%) were purchased from VWR Chemicals (Radnor,
USA).  β-Nicotinamide adenine dinucleotide phosphate disodium salt  (>  93%),  was obtained from
SyncoZymes  (Pudong  Xinqu,  China).  All  the  other  chemicals  and  reagents  were  purchased  from
Sigma-Aldrich and were of analytical grade if not stated otherwise. Buffers, substrate solutions and
other stocks  were prepared freshly and stored at  4 -  6°C for at  most 48 h.  Commercial  Glucose
dehydrogenase GDH-01 was supplied by InnoSyn B.V. (Geleen, The Netherlands) as liquid enzyme
formulation (LF). The LF contained 47 ± 1.4 mg protein mL-1 with 57.5 ± 4.7% GDH-01 content. The
specific activity of the GDH-01 resulted in 310.6 ± 28.5 U mg -1 enzyme. Metrics obtained from the
procedures described in section 2.3 and 2.4.
Methacrylate/styrene resins were kindly donated by Purolite® Life Sciences and stored at 4 - 6 °C. High
density aminoethyl 4BCL agarose (Mana-agarose) was purchased from Agarose Bead Technologies
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(ABT®, Madrid, Spain). Non-functionalized 4BCL agarose was also purchased from ABT® and it was
further functionalized with epoxy groups following the procedure described by Axarli et al [37]. 
2.2. Recombinant production of TmCHMO and GDH-01 in E. coli
Cyclohexanone  monooxygenase  from  T.  municipale (TmCHMO)  was  recombinantly  produced  in
Escherichia  coli in  a  10 L  scale  fed-batch,  high cell-density  fermentation with  glucose as  growth
limiting C-source employing an E. coli K12 derivative and a pBR322 derived expression vectors. 500
mL pre-cultures were used to inoculate 10 kg main culture medium with 100 µg mL -1 neomycin. The
pre-culture  was prepared in standard Luria-Bertani  (LB)  medium supplemented with 100 µg mL -1
neomycin. The fermentation was performed using mineral medium supplemented with 20 g L -1 yeast
extract.  1.5  days  (d)  after inoculation of  the fermenter  as  inducer,  pre-sterilized  L-arabinose was
added to the fermenter to final concentration 0.02 % (w/w). After about 100 hours (h) the biomass
was either harvested by centrifugation (wet cells) or the fermentation broth was used as biocatalyst
as such. The broth contained 412.7 g cell wet weight (cww) per milliliter.  Liquid formulation (LF) of
fermentation was prepared by adding 2 weight equivalents of 100 mM potassium phosphate (KPi)
buffer (pH 7.0) to 1 equivalent of harvested E. coli wet cells (333.3 gcww mL-1) and sonication with an
ultrasound  probe  for  20  minutes  (10  seconds  on,  10  seconds  off)  with  cooling  on  ice.  The  LF
contained 59.4 ± 4.9 mg protein mL-1 with 55.2 ± 0.7% TmCHMO content. The specific activity of the
TmCHMO resulted in 1.76 ± 0.06 U mg-1 enzyme. Metrics obtained from the procedures described in
section 2.3 and 2.4.
2.3. Total protein and enzyme content
The characterization of the samples was carried out exclusively on liquid formulations which were
pre-cleared by centrifugation (3220 g for 15 min). The protein concentration was analyzed by means
of  the  Bradford  Protein  Assay  Kit  (Thermo  Fisher  Scientific,  Waltham,  USA)  using  bovine  serum
albumin (BSA) as standard (0.05 - 0.5 mg mL -1) [38]. The enzyme content was measured using sodium
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (NuPage 12%, Invitrogen, USA) run
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in a Mini-PROTEAN II apparatus (BioRad, USA) following the protocol by Laemmli et al [39]. Precision
Plus  ProteinTM blue  prestained  protein  standards  (BioRad,  USA)  (10  –  250  kDa)  were  used  for
molecular weight determination.  Gels were stained using Coomassie G250 colloidal stain solution
[34% (v/v) ethanol, 2% (v/v) H3PO4, 17% (w/v) (NH4)2SO4 and 0.066% Coomassie G250] and the Image
LAB™ software (BioRad, USA) was used for image processing.
2.4. TmCHMO and GDH-01 activity measurements
The  TmCHMO  activity  was  measured  spectrophotometrically  following  the  NADPH  (0.1  mM)
consumption at 340 nm wavelength (ε = 6.22 mM-1 cm-1) and using cyclohexanone as substrate (0.5
mM)  [35].  The  sample  as  well  as  the  NADPH  and  substrate  were  diluted  in  50  mM  potassium
phosphate buffer (KPi) pH 8. One unit of activity (U) was defined as the amount of enzyme required
to convert 1 µmol of NADPH per minute at 30˚C and pH 8. 
The  GDH-01  activity  was  measured  spectrophotometrically  following  the  NADP+ (0.4  mM)
consumption at 340 nm wavelength (ε = 6.22 mM-1 cm-1) and using (+)-D-glucose as substrate (212.5
mM)  [40].  The  sample  as  well  as  the  NADPH  and  substrate  were  diluted  in  50  mM  potassium
phosphate buffer pH 8. One unit of activity (U) was defined as the amount of enzyme required to
convert 1 µmol of NADP+ per minute at 30˚C and pH 8. 
Activity of TmCHMO and GDH-01 was measured from liquid formulation samples diluted to an extent
until the activity measured was in the linear range of the activity test (0.2 to 5 U mL -1).
2.5. GDH-01 stability studies
The activity decay of four GDH-01 samples (0.8 U mL-1) each one presenting a different pH value (5, 6,
7 and 8) was measured over time. The GDH-01 LF was 10000-fold diluted in 50 mM phosphate buffer
solutions and the pH was adjusted using either 1M HCl or 1M NaOH.
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Furthermore, the activity decay of three samples presenting different enzyme concentrations was
measured after 1 hour incubation at pH 6, 7 or 8 each. The LF containing the over-expressed GDH-01
was  diluted  100-fold,  1000-fold  and  10000-fold  containing  0.47,  0.047  and  0.0047  mg prot  mL -1
respectively. Each of these solutions was then incubated for 1 hour at 30˚C in 50 mM phosphate
buffer solutions (pH 6, 7 or 8).
2.6. Immobilization of GDH-01 onto Methacrylate/Styrene resins.
As a first stage in an immobilization procedure, the supports are loaded with low amounts of enzyme
so that diffusional limitations are avoided. Methacrylate/Styrene resins from Purolite® were studied
offering 20 U of GDH-01 per gram of resin which equals to 64.4 µg of enzyme per gram of support.
A characterization was pursued in order to obtain the retained activity and immobilization yield which
were calculated as explained elsewhere  [40].   Supernatant (precipitated support)  and suspension
(suspended support) were analysed over time until a steady state was reached and in all cases, a
blank (no support)  was also monitored to observe how the enzyme activity was affected by the
protocol’s conditions.
The Purolite® resins offered a variety of features and functionalities (Table S1) and the immobilization
in each case was carried out  according  to  the supplier’s  specifications.  The offered enzyme was
maintained in all cases and the immobilizations proceeded until the supernatant and the suspension
measured activities reached a steady state. The buffered solution contained 10% (w/v) of the carrier
in all cases. 
The epoxy functionalized methacrylates (ECR8204F, ECR8215F and ECR8285) were tested using 50
mM KPi buffer pH 6 mixed with 0.5 M NaCl to increase the ionic strength and favor the attachment.
The amino functionalized carriers (ECR8309F, ECR8315F, ECR8409F and 8415F) were studied using 50
mM KPi buffer pH 6. The immobilization with amino functionalized supports is divided in three steps:
i) ionic adsorption of the enzyme onto the support ii) addition of 10 mM N-(3-dimethylaminopropyl)-
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N′-ethylcarbodiimide (EDC) and incubation for 1.5 hours to promote the covalent binding and iii)
addition of  0.5 M NaCl to desorb all  the protein attached non-covalently.  The non-functionalized
supports (ECR8806F, ECR1061M and ECR1030M) were tested using 50 mM KPi pH 6.  Finally,  the
amino resins were further functionalized with 2% (w/v) glutaraldehyde for 60 min at 25˚C leaving free
aldehyde groups on the surface of the carrier. The immobilization was carried out using 50 mM KPi
buffer pH 6.
A limit was set for both the immobilization yield and the retained activity in order to consider the
carrier as good candidate, 40% for immobilization yield and 20% for retained activity.
2.7. Immobilization of GDH-01 onto functionalized agaroses
The immobilization of GDH-01 onto Epoxy-agarose and Mana-agarose was carried out following the
same procedure as explained above for the epoxy and amino functionalized methacrylate (Purolite®).
20 U of GDH-01 were offered per gram of support to avoid diffusional limitations. For the Epoxy-
agarose, 50 mM KPi buffer pH 6 with 0.5 M NaCl was used. For the Mana-agarose, 50 mM KPi buffer
pH 6 was used and the three steps aforementioned were as well followed. In this case, three different
EDC concentrations were tested: 10, 20 and 30 mM. 
Apart from the characterization stage where low enzyme load is used, the GDH-01 was immobilized
onto Mana-agarose using high (maximum) loads of LF. The immobilization proceeded as explained
above with the difference that in this case, the amount of GDH-01 added was higher (11061.6 U g -1
support). Prior to use the carriers in reaction, they were gently washed with 50 mM KPi buffer pH 6.
The calculation of the immobilization yield and final activity were calculated following the equations
published elsewhere [40].
2.8. Immobilization of TmCHMO onto Mana-agarose
The conditions for the immobilization of TmCHMO onto Mana-agarose were optimized and published
recently  by  Delgove  et  al.  [35].  The characterization of  the enzyme and  the immobilization was
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obviated in this work and high loads of enzyme were used in the experiments performed (86.5 U g -1
support offered). After adsorption of the enzyme onto the carrier, the mixture was incubated with 35
mM EDC for 2 hours. The immobilization yield and final activity were calculated as explained for the
GDH-01. 
2.9. Reaction set up and conditions
The set up used for either the soluble or the immobilized enzyme reactions, consisted of a sealed
jacketed glass reactor (30 mL), a pH controller (Metrohm Titrino plus 877) using 1 M NaOH solution
and it incorporated a propeller stirrer set at 1200 rpm, a thermostat (MGW-LAUDA RC6) set at 30˚C, a
condenser at 6˚C, a compact mass flow regulator (GCR Red-y) to keep a constant air flow of 16 mL
min-1; and a substrate dosing pump (Harvard Pump11).
For the reaction with soluble biocatalysts the following conditions were used: an enzyme load of 10%
(v/v) of TmCHMO broth (57.8 U mL-1 of broth) and 0.5% (v/v) of GDH-01 (8408.8 U mL -1 of LF); 25 mM
KPi pH 7; a TMCH dosing rate of 30 mM h-1  (240 mM final) together with a methanol dosing rate of
1.25% (v/v) h-1 [10% (v/v) final]; [D-glucose] 375 mM and [NADP+] 0.25 mM.
For the reactions catalysed by immobilized enzymes the support loaded varied from 1.7% to 10%
(w/v), the substrate dosing rate was 29 mM h-1 (132.5 mM final concentration) and the methanol
dosing rate was 2.17% (v/v) h-1 [10% (v/v) final concentration]. The rest of conditions were the same
as for the reaction with soluble biocatalysts. 
2.10. Reaction progress determination by GC-FID
Samples (150 µL) were taken periodically from the reactor, weighed and dissolved up to 10 mL with a
solution of acetonitrile containing 0.5 g L-1 of hexadecane that served as Internal Standard (IS). The
mixture was centrifuged to remove insoluble biomass and the supernatant was analyzed by a gas
chromatograph (GC) equipped with a flame ionization detector (FID). The concentration of substrate
and products were determined using calibration curves.
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The  centrifuged  supernatant  samples  containing  trimethyl-cyclohexanone  and  trimethyl-ε-
caprolactones were analyzed using a 7890A gas chromatograph (Agilent Technologies, USA) equipped
with a HP-5 column (30 m, 0.32 mm, 0.25 µm df, Agilent Technologies). The column temperature was
maintained at  60°C for  2  minutes,  increased up to 300°C at  10°C min -1 and it  was held  at  final
temperature for 2 minutes. The injector temperature was kept at  200°C; for the flame ionization
detector, the temperature was 300°C. Hydrogen was used as a carrier gas at a flow rate of 40 mL min -1
and air at 450 mL min-1. The retention times observed were: 8.5 min for the substrate 1, 11.9 min for
lactone 1b, 12.1 min for lactone 1a and 15.8 min for the IS. 
2.11. Re-usability of immobilized derivates towards the synthesis of trimethyl-ε-caprolactone
Reactions performed using either one or both enzymes immobilized, were performed in a similar
fashion as for the soluble reactions. The difference was that once the reaction was finished, the
whole reactor content was filtered and the derivate/s were washed gently with 50 mM KPi buffer pH
7. The immobilized enzyme was placed back into the reactor with no further treatment and the next
cycle of reaction started.
3. Results and discussion
3.1 Stability of GDH-01 in different pHs and concentrations
As introduced previously, the aim of this work was the immobilization of the novel GDH-01 and the
re-utilization of this enzyme together with the TmCHMO in the synthesis of trymethyl-ε-caprolactone.
As  opposite  to  the  TmCHMO,  the  GDH-01  has  never  been  immobilized  before,  that  is  why
characterization  regarding  its  stability  was  required.  When immobilizing,  the  media  pH  must  be
chosen taking into account the support utilized and the activity decay of the enzyme at that certain
pH. The results obtained are represented in Figure 2 A.
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Figure 2. GDH-01 stability studies. A) GDH-01 relative activity along time measured at different pH values (of KPi
buffers): pH 5 (black triangles and discontinuous line), pH 6 (black squares and continuous line), pH 7 (black
rhombus and dotted line) and pH 8 (black circles and combined discontinuous spot-line-spot). The initial activity
of the samples was 0.8 U mL-1; 10000-fold dilution of the initial liquid formulation. B) GDH-01 relative activity
after 1 hour incubation at three different pHs: pH 6 (black bars), pH 7 (grey bars) and pH 8 (white bars); and
three different protein concentrations. The initial activities of the samples were 0.8 U mL -1, 8 U mL-1 and 80 U
mL-1 for the 0.0047,  0.047 and 0.47 mg protein mL-1 respectively.  The error  bars of  both figures,  A and B,
correspond to the standard error calculated from at least two replicates.
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As it can be observed in Figure 2 A, when GDH-01 was diluted in pH 8 buffer, it was almost completely
deactivated after one hour. On the other hand, pH 6 turned out to be the most favorable for this
enzyme which maintained 50% of the activity after 3.5 hours. In Figure 2 B, the LF containing GDH-01
was incubated for 1 hour at three different pHs (6, 7 and 8) and three different protein concentrations
were applied for each pH. The graph shows that, at pH 7 and 8, the enzyme is deactivated to different
extent depending on the concentration it is in. The lowest concentrated sample suffers the highest
loss of activity. At pH 6 though, the relative activity after 1 hour is almost the same for the three
enzyme concentrations. Diluting the GDH-01 LF in a solution containing 5 mg mL -1 of Bovine Serum
Albumin (BSA) or pre-coating the vial with BSA did not improve the GDH-01 stability at pHs different
from 6. 
The stability dependency on the enzyme concentration has also been observed previously on other
biocatalysts but not with GDH-01. The dilution of the enzyme below the concentration of the binding
constant of its subunits or prosthetic groups can provoke the loss of the protein quaternary structure
or the loss of the essential prosthetic group [41].
The  TmCHMO  stability  was  not  measured  due  to  the  existence  of  previous  works  about  its
immobilization [35].
3.2 Immobilization of GDH-01. Characterization of different supports. 
3.2.1 Methacrylate/Styrene based supports
Glucose dehydrogenase is used in this target reaction as a cofactor regeneration enzyme. In the case
of the novel GDH-01, the GDH studied in this work, no publications exist regarding its immobilization
as far as the authors know. Once the stability of the enzyme at different pHs was known, the goal was
finding a suitable support for immobilization.
A set of 14 different methacrylate/styrene resins covering a broad range of enzyme carrier features
were obtained from Purolite® Technologies.  The materials  supplied had different:  pore diameters
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(300  -  1800 Å),  enzyme-carrier  interactions  (ionic,  covalent  and  hydrophobic),  functional  groups
(epoxy, amino and aldehyde), linker lengths (C2 - C18), material matrices (methacrylate and styrene)
and particle sizes (150 – 710 µm). A detailed description of each carrier and the results obtained for
the immobilization of GDH-01 can be found in the Appendix A (Table A.1). 
The  supports  that  resulted  in  at  least  40%  immobilization  yield  and  20%  retained  activity  are
presented  in  the  table  below  (Table  1).  As  can  be  seen,  only  four  supports  fulfilled  the
aforementioned  criteria:  one  amino  functionalized  support  (ECR8415F)  and  three  aldehyde-
functionalized supports (ECR8315F, ECR8409F and ECR8415F).
Table  1.  Results  regarding  the  immobilization of  GDH-01 onto  Methacrylate/Styrene  (Purolite®)  resins  and
description of the support’s features. Only those experiments with at least 40% immobilization yield and 20%
retained  activity  are  presented.  Further  information  regarding  other  supports  screened  can  be  found  in
Supplementary information, Table S1. The standard error (± %) was calculated from at least two replicates. 
Code
Functional
group
(Linker)
Matrix Interaction
Pore
diameter
(Å)
Particle
size
(µm)
Immobilization
(%)
Retained
acitivty
(%)
ECR8415F Amino (C6) Methacrylate Ionic/Covalent 1200 -1800
150 -
300 40.8 ± 2.2 21.3 ± 3.5
ECR8315F Aldehyde(C7) Methacrylate Ionic/Covalent
1200 -
1800
150 -
300 99.9 ± 0.1 23.9 ± 3.4
ECR8409F Aldehyde(C11) Methacrylate Ionic/Covalent
600 -
1200
150 -
300 100 ± 0.0 22.5 ± 2.6
ECR8415F Aldehyde(C11) Methacrylate Ionic/Covalent
1200 -
1800
150 -
300 100±0.0 28.0 ± 5.1
When working with amino functionalized resins, as is the case of ECR8415F, the immobilization is
carried out in three steps. First, an ionic interaction between the positively charged amino groups of
the support and the negatively charged carboxyl groups of the enzyme occurs. In this first binding,
99.1  ±  0.1% immobilization yield and 60.0  ±  4.1% retained activity were obtained with ECR8415F.
However, the optimized pH for the target reaction is 7, which changes the positive charge of the
resin’s amino groups, desorbing the enzyme from the carrier. Thus, an agent promoting a covalent
bond  formation  is  required  for  its  use  in  the  target  reaction.  N-(3-dimethylaminopropyl)-N -′
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ethylcarbodiimide (EDC) was chosen due to its high solubility in water. The immobilization yield and
retained activity obtained were 40.8 ± 2.2% and 21.3 ± 3.5%, respectively. The EDC is often associated
with  enzyme deactivation,  however,  in  this  case,  the  low immobilization yield  indicates  that  the
amount of EDC added was not enough to covalently bind all the enzyme offered and a major part of
the initially attached GDH-01 was desorbed when the NaCl was introduced.
Regarding glutaraldehyde functionalized supports (ECR8315F, ECR8409F and 8415F), the results are
similar between the three, even though the supports differ in linker lengths and pore diameters. In
the three cases, the GDH-01 showed immobilization yields close to 100% meaning that the enzyme
presents high affinity for the carrier. However, either due to miss-orientation, unfolding or stacking,
the enzyme attached was significantly deactivated (low retained activities) showing less than 30% of
retained activity in all cases.
The methacrylate/styrene resins are rather hydrophobic which can contribute to enzyme deactivation
during  immobilization.  Taking  into  account  that  all  the  supports  tested  so  far  had  different
functionalizations but similar matrices, new materials made out of more hydrophilic materials were
to be tested. In this sense, agaroses were the first choice for further investigation, aiming to obtain
immobilized derivatives with higher retained activities [42].
3.2.2 Agarose based matrices: Epoxy- and Mana-agarose
As  mentioned  before,  more  hydrophilic  matrices  were  tested  presenting  two  different
functionalizations.  An  epoxy  functionalized  agarose  and  an  amino functionalized  agarose  (Mana-
agarose) were studied as potential immobilization supports for GDH-01.  
The Epoxy-agarose immobilization is usually pursued at alkaline pH. However, the studies performed
with GDH-01 showed a very poor stability of the enzyme at pH 8 (Figure 2 A). The immobilization was
therefore conducted at pH 6 and 0.5 M of NaCl were added in order to increase the ionic strength of
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the medium to promote the binding. The results showed low affinity of the enzyme for the support
and a slight over-activation. At the end, 29.5 ± 7.3% retained activity were obtained.
The  amino  functionalized  agarose  (Mana-agarose)  immobilization  proceeds  like  the  amino
functionalized resins from Purolite®. The immobilization takes place in three steps: i) ionic adsorption,
ii) covalent binding and iii) desorption with 0.5 M NaCl (Figure 3). 
Figure 3. Immobilization course of the GDH-01 onto amino functionalized agarose (Mana-agarose) using 10 mM
EDC concentration and offering 20 units of GDH-01 activity (64.4 µg of enzyme) per gram of agarose. The graph
shows  the  activity  of  the  blank  (black  circles  and  continuous  line),  the  supernatant  (black  triangles  and
discontinuous  line)  and the  suspension  (black  rhombus and dotted line)  along time.  The immobilization is
divided in the three different phases: i) ionic adsorption of the enzyme to the carrier (Ads), ii) incubation with
the covalent bond promoter, EDC (EDC) and iii) desorption of the unattached enzyme with 0.5 M NaCl (NaCl).
The  results  regarding  the  Mana-agarose  immobilization  are  presented  in  Table  2.  As  it  can  be
observed in the second and third columns, 98.4 ± 0.2% of the initial GDH-01 bound to the agarose by
ionic interaction and a slight over-activation occurred (retained activity 105.5 ± 3.8%). As explained
for the amino-methacrylate supports though, the pH of the reaction (pH 7) does not allow an ionic
immobilization to be used. Results obtained after covalent binding formation reached 76.3 ± 0.7 %
and  62.6  ±  2.3%  of  immobilization  yield  and  retained  activity,  respectively  (Figure  3),  which
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
represents  a  high  significant  improvement  compared  to  the  results  obtained  with  the
methacrylate/styrene matrices.
Table 2. Immobilization of GDH-01 onto amino functionalized agarose (Mana-agarose) using three different EDC
concentrations. 20 units of GDH-01 activity (64.4 µg of enzyme) were offered per gram of agarose. The standard
error (± %) was calculated from at least two replicates.
Ionic Adsorption Covalent binding
[EDC] Immobilization Yield(%)
Retained Activity
(%)
Immobilization Yield
(%)
Retained Activity
(%)
10
98.4 ± 0.2 105.5 ± 3.8
76.3 ± 0.7 62.6 ± 2.3
20 94.1 ± 0.1 47.2 ± 3.3
30 98.2 ± 0.1 44.2 ± 0.2
Due to the promising results obtained with Mana-agarose, in addition to the use of 10 mM of EDC,
two different concentrations were also tested (20 mM and 30 mM) aiming to obtain an immobilized
derivate  with  the  highest  activity  possible  (Table  2).  However,  even  though  when  using  higher
concentrations  of  EDC  the  immobilization  yield  increased  more  than  1.2-fold,  the  enzyme  got
deactivated and the retained activity dropped to 15.4% and 18.4%, respectively. That is why 10 mM
of  EDC  was  chosen  as  the  best  condition  albeit  23.7%  of  the  initial  activity  remained  in  the
supernatant.  The immobilization onto  Mana-agarose represents  a  step forward compared to the
methacrylate/styrene (Purolite®) supports. The retained activity in this case is 2.94-fold higher than
the  amino  functionalized  methacrylate  (ECR8415F)  and  2.24-fold  higher  than  the  aldehyde
functionalized methacrylate (ECR8415F), the best candidates from the previous trials. As it happened
with the other resins, this is the first time that the successful immobilization of GDH-01 onto Mana-
agarose is reported. This support was chosen to study the re-cyclability capacity of GDH-01 in the
synthesis of trimethyl-ε-caprolactone. 
3.3 Immobilization of GDH-01 and TmCHMO on Mana-Agarose. Maximum loading capacity
The maximum quantity of GDH-01 and TmCHMO that can be attached to Mana-agarose was studied.
Different amounts of enzyme were immobilized onto the support in order to determine this value.
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Since mass transfer limitation could occur at high enzyme loads, retained activities obtained during
the  immobilization  characterization  at  low  loads  were  used  here  to  calculate  the  theoretical
maximum loading capacity in terms of activity units [Table 3, Final activity (U g-1 support)].
Table 3. Immobilization of GDH-01 onto Mana-agarose using maximum loads of enzyme per gram of support. 
The covalent immobilization of GDH-01 was carried out using 10 mM EDC for 1.5 hours while the TmCHMO was 
incubated for 2 hours with 35 mM of EDC. 
Enzyme Activity offered (U g
-1
support) Final activity (U g
-1 support) Retained protein (mgprotein g-1 support)
GDH 11061.6 3692.5 23.1
TmCHMO 86.5 53.2 67.7
The immobilization of TmCHMO was carried out using the optimized conditions published recently by
Delgove et at. [35]. The amino-functionalized agarose was used as a carrier and 35 mM of EDC were
applied as a covalent bond promoter. The obtained retained activity at low loads in that study was
62.4  ±  2.1%.  The results  obtained regarding  the immobilization of  TmCHMO using  high loads of
enzyme,  are  shown in  Table  3.  The maximum  loading capacity  of  TmCHMO resulted in  67.7  mg
protein g-1 support and 53.2 U g-1 support. 
Regarding  the  GDH-01,  23.1  mg  protein  g-1  support  were  immobilized  using  10  mM  EDC
concentration. According to the retained activity obtained during the characterization (62.6 ± 2.3%),
3692.5 U g-1 support could be loaded onto Mana-agarose (Table 3).
3.4 Synthesis of trimethyl-ε-caprolactone
3.4.1 Soluble enzymes
Aiming  to  compare  the  performance  of  the  immobilized  derivatives  with  the  soluble  enzyme,  a
reaction was  run  firstly  using  non-immobilized  TmCHMO and GDH-01.  Different  metrics  such  as
biocatalyst yield and total product synthesized were used for comparison. The conditions published
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recently [43] and further optimized by the authors (data not shown) were mimicked in this study at
30 mL scale using 10% (v/v) load of TmCHMO fermentation broth and 0.5% (v/v) GDH-01 LF.
The reaction course can be seen in  Figure 4. A continuous substrate feeding strategy was used in
order to avoid substrate inhibition which has been observed for this enzyme [18,43]. Even though the
substrate was continuously added, certain amount of it  was accumulated at the beginning of the
reaction. At the same time, as it can be seen in the graph, the amount of NaOH added to control the
pH  is  well  aligned  with  the  product  formed  and  it  serves  as  good  indicator  of  the  reaction
performance.  At  the end though, after 24 h,  a gap exists  between the titration and the product
analyzed. This can be associated with product solubility limitations  [43]. In order to obtain reliable
values for conversion and yield at  the end of the reaction the reactor was worked up by adding
acetonitrile which solubilized the whole substrate and product content.
Figure 4. Synthesis of trimethyl-ε-caprolactone using the enzymes in its soluble forms: the TmCHMO broth and
GDH-01 LF.  The graph shows the reaction course of TMCH (white circles), CHL (black circles), NaOH addition
(black line), substrate dosing (discontinuous line) and mass balance (combined discontinuous spot-line-spot).
Conditions:  enzyme load 10% (v/v) of  TmCHMO broth (57.8 U mL-1 of  Broth) and 0.5% (v/v) of GDH-01 LF
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(8408.8 U mL-1 of LF); temperature 30°C; stirring rate 1200 rpm; air flow 16 mL min -1; pH 7; [TMCH] 30 mM h-
1(240 mM final); Methanol 1.25% (v/v) h-1  [10% (v/v) final]; [D-Glucose] 375mM; [NADP+] 0.25mM; titration
solution 1M NaOH.
The conversion and yield of the reaction after 24 h were 92.1 ± 4.5% and 92.0 ± 3.3% respectively.
The amount of NaOH added was 101.2  ±  1.9% of the final substrate dosed (on molar basis). The
product concentration reached was 34.5 ± 1.2 g L-1 and the biocatalyst yield was 10.5 ±  2 g CHL g-1
TmCHMO and 255.0 ± 9.2 g CHL g-1 GDH-01. 
3.4.2 Immobilized enzymes
From an industrial point of view, the possibility of re-using enzymes in various reaction cycles can
significantly improve the process throughput. For example, when re-cycling,  the required enzyme
decreases and it facilitates the product isolation and purification among others.
Three sets of reactions were performed using one of the two enzymes immobilized and the other in
its soluble form or both enzymes immobilized. Several  disadvantages are sometimes observed when
working  with  immobilized  enzymes:  substrates/product  mass  transfer  limitations,  lower  oxygen
transfer rates, poor distribution of the carrier in the reactor, enzyme selectivity alterations, etc. 
The  reaction  time  was  reduced  (6  h),  total  conversion  was  prioritized  over  high  product
concentrations and substrate accumulation was to be avoided. For these reasons, the initial substrate
concentration  was  reduced,  compared  to  the  reaction  with  soluble  biocatalysts.  In  each  set  of
reactions, re-cycling of the immobilized enzyme/s was intended up to 6 cycles. The results can be
seen in the graphs below (Figure 5, A, B and C) and a final summary is presented in Table 4. 
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Figure 5. Reaction cycles using either one or both enzymes immobilized. Each graph shows the reaction yield
(grey  bars),  the  CHL  formation (black  circles  and  continuous  line)  and  the  maximum  reaction rate  (white
rhombus). A) TmCHMO immobilized [3 g of support loaded (53.2 U g-1 of support)] and 0.5% (v/v) of GDH-01 LF
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(8408.8 U mL-1 of LF),  B) GDH-01 immobilized [1.5 g of support loaded (1624.9 U g-1 of support)]  and 10%
TmCHMO LF (46.7 U mL-1 of LF) and C) TmCHMO immobilized [2.5 g of support loaded (53.2U g -1 of support)]
and GDH-01 immobilized [0.5 g of support loaded (3692.5 U g -1 of support)]. Conditions:  temperature 30°C;
stirring rate 1200 rpm; Air flow 16mL min-1; pH 7; [TMCH] 29 mM h-1(132.5 mM final); Methanol 2.17% (v/v) h-1
[10% (v/v) final]; [D-Glucose] 375mM; [NADP+] 0.25mM; titration solution 1 M NaOH.
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Table 4. Final summary of the reaction with soluble biocatalysts and the reactions where either one or both of the enzymes were immobilized.
Figure Enzyme Immob Soluble Activity in thereactor (U mL-1)
Enzyme loaded in
the reactor (mg) CHL formed (mg)
Biocatalyst yield (g
CHL g-1 enzyme)
Improvement
factor
Figure 4.
TmCHMO X 5.8 98.5
1033.8
10.5
GDH-01 X 42.0 4.1 254.6
Figure 5. A)
TmCHMO X 5.3 90.7
2927.9
32.3 3.1
GDH-01 X 42.0 24.4 120.2 0.5
Figure 5. B)
TmCHMO X 4.7 477.6
2816.5
5.9 0.6
GDH-01 X 81.2 7.8 358.9 1.4
Figure 5. C)
TmCHMO X 4.4 75.6
2818.6
37.3 3.6
GDH-01 X 61.5 5.9 474.2 1.9
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The reaction containing  immobilized  TmCHMO and soluble  GDH-01 LF  showed good recyclability
capacity of the derivate presenting 55% yield in the sixth cycle (Figure 5 A). The maximum rate of the
reaction decreased from cycle to cycle as did the final yield. The titration, on the other hand, was
higher than the product formation. In the first cycle 150.3% NaOH was added compared with the final
added  substrate  concentration.  This  over-titration  effect  decreased  along  the  cycles  and  even
reverted in the last two. The titration in the fifth and sixth cycles was 59.5% and 39.4% whilst the
yield was 67.8% and 55.0%. A possible explanation for this behavior could be found in the support’s
nature. The free and positively charged amino groups present on the surface of the carrier at the end
of the immobilization, lose their proton when placed in pH 7 medium, causing an extra acidification,
which was compensated by the auto-titration of NaOH base.
The reaction where GDH-01 was used in its immobilized form and the TmCHMO was added as LF is
represented in Figure 5 B.  The results show that the yield was maintained during the first three
cycles (94 - 95%) and then continuously dropped until it reached 40.2% in the sixth. Over-titration
was also observed in this case (142.6% in the 1st cycle) and the maximum rate decay of the reaction
was well aligned with the yield, as it happened with the immobilized TmCHMO. It should be noticed
that the GDH-01 immobilized derivate used in this case was loaded with lower amount of enzyme
(2765.4 U g-1 support) and so it presented lower final activity (1624.9 U g -1 support) compared with
the derivate previously reported (Table 3, 3692.5 U g-1 support). At the same time, in order to ensure
proper recovery of the resin in the filtration and washing operations, 5% (w/v) support load was
considered  to  be  the  minimum  required.  At  the  end,  the  GDH-01  activity  offered  was  higher
compared to the soluble reaction (42.0 U mL-1 compared to 81.2 U mL-1).
The last  reaction was performed with both TmCHMO and GDH-01 immobilized (Figure 5 C).  The
course  of  the  reaction  cycles  was  similar  to  the  previous  experiments.  Both  enzymes  could  be
recycled and 57.2% yield was reached in the sixth cycle. The yield in the first two cycles was almost
complete reaching 91.6 and 98.4%, while in the third cycle the yield dropped to 80.7%. The over-
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titration effect observed in the previous sets of reactions (Figure 5 A and B), was less prominent in
this one. In the first cycle 107% titration and 91.6% yield were obtained. Regarding the maximum
rate, no significant differences were observed and the rate decay was well aligned with the yield. The
activity offered of each enzyme differed from the previous reactions with immobilized enzymes: 17%
less TmCHMO Units and 24.3% less GDH-01 Units. This was due to the maximum support amount
that can be loaded to ensure a proper mixing [10% (w/v)] and the GDH-01/TmCHMO activities of the
immobilized  derivatives.  Furthermore,  when  comparing  the  three  reactions,  the  reaction  with
immobilized GDH-01 and soluble  TmCHMO maintained almost  full  yield  for  the first  three cycles
(Figure 5 B) while the reaction with immobilized TmCHMO and soluble GDH-01 (Figure 5 A) presented
91.5% in the second cycle and 84.3% in the third. For this reason, TmCHMO was considered to be,
most probably, the enzyme limiting the reaction cycles. 
A comparative table with the final metrics is presented (Table 4).  Two parameters are shown for
comparative purposes: the total CHL formed (mg) and the biocatalyst yield (mg CHL mg -1 of enzyme).
Biocatalyst yield was used as the most suitable process metric to compare all the reactions settings
since it takes into account the grams of enzymes loaded in the reaction which, as already mentioned,
could not be maintained constant in all experiments performed.
 The improvement factor refers to the biocatalyst yield obtained in each immobilized set of reactions
compared with the biocatalyst yield of the soluble reaction. When looking at the three reactions with
immobilized derivates (Figure 5 A, B and C) the amount of CHL formed almost triples the amount
obtained in the soluble reaction. At the same time, the amount of immobilized GDH-01 added is also
higher. As it can be seen, when immobilized, the TmCHMO improves the amount of product that the
enzyme is able to catalyze by a factor of 3.1 (Figure 5 A) and 3.6 (Figure 5 C). On the other hand, the
immobilized GDH-01 is able to regenerate the NADPH cofactor until 1.4 and 1.9 times more CHL is
synthesized by the soluble TmCHMO LF or immobilized one, respectively. 
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This work represents a step forward in the utilization of the immobilized TmCHMO compared with a
previous  publication  [35].  The  amount  of  CHL  synthesized  with  both  enzymes  immobilized  was
increased by a factor of 5.2 and the biocatalyst yield obtained was improved by a factor of 2.2 and 14,
for  the  TmCHMO  and  the  GDH-01  respectively.  In  the  above  mentioned  work,  a  GDH  from
Thermoplasma acidophilum (GDH-Tac) was used instead of GDH-01.
Regarding the cofactor regeneration enzyme, it is the first time that the GDH-01 has been repetitively
used in six reaction cycles in the synthesis of a product with industrial interest at high substrate and
product concentrations. 
4. Conclusions
The immobilization of the novel and highly active (310.6 ± 28.5 U g-1 enzyme) Glucose dehydrogenase
GDH-01 has proven successful for the first time. The enzyme presented acceptable retained activities
(>20%) in four out of the fourteen supports that were tested from Purolite®. Furthermore, the GDH-
01 was adsorbed onto amino functionalized agarose presenting significantly improved metrics, an
immobilization yield of 98.4 ± 0.2% and a slight over-activation with  105.5 ± 3.8% retained activity.
When  the  adsorbed  derivate  was  further  treated  with  a  covalent  bond  promoter  (EDC),  the
immobilization yield obtained was 76.3 ± 0.7% and the retained activity 62.6 ± 2.3%. A final derivate
could be obtained presenting 3692.5 U g-1 of support. 
The immobilization of TmCHMO performed previously by Delgove  et al. [35] could be mimicked in
this  study  and  highly  loaded  and  active  derivates  (53.2  U  g-1 of  support)  were  obtained  for  its
application in the synthesis of trimethyl-ε-caprolactone. At the same time, the immobilized GDH-01
could be used as cofactor regeneration enzyme. A set of five reactions with 6 reaction recycles were
carried out using either one or both of the enzymes in its immobilized forms. The biocatalyst yield
obtained in each case for the immobilized enzymes was compared with a model reaction where both
enzymes were in its soluble form. The best results were obtained with both enzymes immobilized.
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The total CHL produced in 6 different reaction cycles (30 mL, [TMCH] = 132.5 mM each cycle) was
2818.6 mg. The biocatalyst yields obtained were 3.6 times and 1.9 times higher for the TmCHMO and
the GDH-01 respectively, compared with the soluble reaction.
This  work  represents  a  step  forward  compared  with  the  previous  research  regarding  the
immobilization of TmCHMO and synthesis of CHL. When both enzymes were used immobilized, the
total product formed was increased 5.2-fold and the TmCHMO biocatalyst yield was increased 2.2-
fold compared with the aforementioned publication [35]. Although the most significant improvement
was observed in the biocatalyst yield of GDH-01 compared with the GDH used in the previous work,
GDH-Tac.  The  biocatalyst  yield  as  gram  product  obtained  per  gram  (immobilised)  enzyme  was
increased 14-fold.
As it happens with any biochemical process, there are parameters that could be better adjusted and
higher yields could potentially be achieved. The first parameters that the authors would work on
would be the variation of  the immobilized GDH-01:TmCHMO ratio,  and the increase of  the final
substrate concentration. Comparing the soluble and immobilized reactions, the amount of enzyme
offered does not differ much, however, the final substrate concentration was 1.8 times lower with the
immobilized derivates. 
In conclusion, this work represents a new input for the potential implementation of TmCHMO and
GDH-01 in the industrial production of ε-caprolactone derivatives and other lactones. 
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6. Appendix A
Table  A.1.  Methacrylate/styrene  (Purolite®)  screening  set  of  resins  and  the  immobilization  results
(immobilization yield and retained activity) for the GDH-01. 
Code Functionalgroup (Linker) Matrix Interaction
Pore
diameter
(Å)
Particle
size (µm)
Immobili
zation
(%)
Retained
acitivty
(%)
ECR8204F Epoxy Methacrylate Covalent 300-600 150-300 0±2.9 21.9±4.9
ECR8215F Epoxy Methacrylate Covalent 1200-1800 150-300 15.8±2.8 23.6±1.3
ECR8309F Amino (C2) Methacrylate Ionic/Covalent 600-1200 150-300 66.9±1.1 19.1±0.9
ECR8315F Amino (C2) Methacrylate Ionic/Covalent 1200-1800 150-300 76.1±0.7 18.9±0.2
ECR8409F Amino (C6) Methacrylate Ionic/Covalent 600-1200 150-300 36.9±2.1 11.9±4.4
ECR8415F Amino (C6) Methacrylate Ionic/Covalent 1200-1800 150-300 40.8±2.2 21.3±3.5
ECR8285 Epoxy (C4) Methacrylate Ionic/Covalent 400-600 300-710 100±0.0 9.7±1.1
ECR8806F None (C18) Methacrylate Hydrophobic 500-700 150-300 99.7±0.1 6.5±0.5
ECR1061M None Styrene/Methacrylic Hydrophobic 600-750 300-710 95.9±0.3 3.1±0.6
ECR1030M None Styrene/Methacrylic Hydrophobic 200-300 300-710 93.7±1.8 3.1±0.8
ECR8309F Aldehyde (C7) Methacrylate Ionic/Covalent 600-1200 150-300 99.5±0.0 16.2±1.1
ECR8315F Aldehyde (C7) Methacrylate Ionic/Covalent 1200-1800 150-300 99.9±0.1 23.9±3.4
ECR8409F Aldehyde(C11) Methacrylate Ionic/Covalent 600-1200 150-300 100±0.0 22.5±2.6
ECR8415F Aldehyde(C11) Methacrylate Ionic/Covalent 1200-1800 150-300 100±0.0 28±5.1
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